Stanford neuroscientist Andrew Huberman says the real AI arms race is about controlling your brain

Stanford neuroscientist Andrew Huberman predicts the next major AI arms race will focus on controlling and manipulating human brain activity, rather than simply developing better algorithms. Huberman stated that companies like OpenAI, Meta, and Anthropic will eventually evolve into biotech firms, working to read and alter brain activity without the need for invasive implants.

The goal is to non-invasively read and write from the brain, enabling tools to help individuals fall asleep, learn, focus, or regulate stress. Huberman envisions a future where non-invasive devices could boost motivation during challenging tasks and then turn it off to facilitate recovery. While such devices are still in the early stages of development, consumer neurotech devices like Neurable, Mave, Halo Neuroscience, and LIFTiD are already available, offering various brain stimulation techniques to improve concentration.

Huberman anticipates that sleep technology, eye movement monitoring, and autonomic nervous system influence will be the first focus of this new wave of AI-driven brain manipulation. He believes that entrepreneurs will soon view implantable vagus-nerve stimulators, which can affect alertness and have clinical applications, as commonplace as cosmetic piercings.

However, Huberman also acknowledges the concern surrounding the vulnerability of the entire brain to noninvasive control, emphasizing the need for safety mechanisms in these devices. He remains optimistic about the potential of this new technology, stating that existing tools like caffeine, medication, exercise, and breathwork will be replaced by more personalized and precise methods that leverage AI to optimize brain states for focus and learning.